Compare ARTL & ENR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARTL | ENR |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 1.4B |
| IPO Year | N/A | N/A |
| Metric | ARTL | ENR |
|---|---|---|
| Price | $1.27 | $22.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $30.00 | $25.00 |
| AVG Volume (30 Days) | 35.2K | ★ 1.6M |
| Earning Date | 03-02-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 5.29% |
| EPS Growth | N/A | ★ 281.77 |
| EPS | N/A | ★ 3.02 |
| Revenue | N/A | ★ $2,999,900,000.00 |
| Revenue This Year | N/A | $2.92 |
| Revenue Next Year | N/A | $0.76 |
| P/E Ratio | ★ N/A | $7.52 |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $1.15 | $16.77 |
| 52 Week High | $28.60 | $31.78 |
| Indicator | ARTL | ENR |
|---|---|---|
| Relative Strength Index (RSI) | 30.68 | 54.20 |
| Support Level | $1.35 | $21.88 |
| Resistance Level | $1.52 | $23.52 |
| Average True Range (ATR) | 0.14 | 0.99 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 4.29 | 40.85 |
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.